Clinical Trials
15 trialsNCT00253526 2015-04-28
Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00324831 2013-12-18
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
Phase 3 Suspended
NCT00002482 2013-11-06
Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00003455 2013-07-10
Antineoplaston Therapy in Treating Women With Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003486 2013-07-10
Antineoplaston Therapy in Treating Patients With Colon Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003502 2013-07-10
Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003514 2013-07-10
Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003517 2013-07-10
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003536 2013-07-10
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00112879 2013-07-10
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00427570 2013-06-24
Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT00066417 2013-05-01
Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00025051 2013-03-22
Celecoxib in Preventing Skin Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00098917 2008-01-28
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00265928 2008-01-28
Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Terminated